Hyperfine, Inc. (HYPR)

US — Healthcare Sector
Peers: OSA  NPCE  KIDS  ANIK  HSKA  PAVM  LIVN  ELMD  SRDX  LUNG  IRMD  OFIX  ITGR  INGN  APYX 

Automate Your Wheel Strategy on HYPR

With Tiblio's Option Bot, you can configure your own wheel strategy including HYPR - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol HYPR
  • Rev/Share 0.155
  • Book/Share 0.5696
  • PB 1.0578
  • Debt/Equity 0.0
  • CurrentRatio 6.0663
  • ROIC -0.9524

 

  • MktCap 46898511.0
  • FreeCF/Share -0.4784
  • PFCF -1.295
  • PE -1.132
  • Debt/Assets 0.0
  • DivYield 0
  • ROE -0.7419

 

  • Rating C-
  • Score 1
  • Recommendation Strong Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 4
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

HYPR Stock Jumps on NVIDIA Partnership to Advance AI Neuroimaging
HYPR
Published: March 18, 2025 by: Zacks Investment Research
Sentiment: Positive

Hyperfine partners with NVIDIA to integrate advanced AI into its Swoop MRI system, aiming to transform neuroimaging with faster and more accessible brain scan solutions.

Read More
image for news HYPR Stock Jumps on NVIDIA Partnership to Advance AI Neuroimaging

About Hyperfine, Inc. (HYPR)

  • IPO Date 2021-01-28
  • Website https://hyperfine.io
  • Industry Medical - Devices
  • CEO Ms. Maria Sainz
  • Employees 111

Hyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products. It offers Swoop Portable MR imaging system to address an unmet need in point-of-care medical imaging through a combination of hardware and software services. The company was incorporated in 2014 and is based in Guilford, Connecticut.